Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tsuchiya, T.
Right arrow Articles by Mutai, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchiya, T.
Right arrow Articles by Mutai, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Skeletal Myopathy in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene

Takayuki Tsuchiya

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan, Tsuchiya.Takayuki@ mf.m-pharma.co.jp

Kiyoshi Kobayashi

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Tetsuya Sakairi

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Kazuhiro Goto

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Miyoko Okada

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Fumiko Sano

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Jiro Sugimoto

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Tetsuo Morohashi

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Toshimi Usui

Central Institute of Experimental Animals, Miyamae-ku, Kawasaki 216-0001, Japan

Mamoru Mutai

Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals, Inc, Chiba-ken 292-0812, Japan

Skeletal myopathy was found in almost all-transgenic mice carrying the human prototype c-Ha-ras gene (rasH2 mouse). Microscopically, variation of the muscle fiber size, centrally placed nuclei, regenerating fibers, and interstitial fibrosis were evident; hyalinization and necrosis were sometimes observed in the skeletal muscle (femoralis and pectoralis) of the rasH2 mice. Inflammatory changes in the skeletal muscle or abnormality of adjacent peripheral nerve were not observed. The features were essentially similar to those of muscular dystrophy. Although the severity was relatively mild compared to 34-week-old rasH2 mice, the skeletal myopathy was also observed in younger male (10 weeks of age) rasH2 mice. In nontransgenic littermates, skeletal myopathy was not observed. The mRNA of human c-Ha-ras product was detected in femoral muscle from the rasH2 mice by RT-PCR. In conclusion, these data suggest that skeletal myopathy is occurring in almost all rasH2 mice. Integration of c-Ha- ras gene is thought to be crucial to pathogenesis of skeletal myopathy in the rasH2 mice. Further characterization of the muscular lesion and its pathogenesis are needed to explore the possibility of rasH2 mouse becoming a new model for muscular dystrophy.

Key Words: Skeletal muscle • muscular dystrophy • rasH2 mouse • ras gene • histopathology • spontaneous.

References

  • Anderson JE, Ovalle WK, Bressler BH (1987). Electron microscopic and autoradiographic characterization of hind limb muscle regeneration in the mdx mouse. Anat Rec 219: 243—257.[CrossRef][Medline] [Order article via Infotrieve]
  • Bos JL (1989). ras oncogenes in human cancer: A review. Cancer Res 49: 4682—4689.[Abstract/Free Full Text]
  • Bulfield G., Siller WG, Wight PA, Moore KJ (1984). X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189— 1192.
  • Carpenter JL, Hoffman EP, Romanul FC, Kunkel LM, Rosales RK, Ma NS, Dasbach JJ, Rae JF, Moore FM, McAfee MB (1989). Feline muscular dystrophy with dystrophin deficiency. Am J Pathol 135: 909—919.[Abstract]
  • Cohen JB, Levinson AD (1988). A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature 334: 119—124.[CrossRef][Medline] [Order article via Infotrieve]
  • Cooper BJ, WinandNJ, Stedman H., Valentine BA, Hoffman EP, Kunkel LM, Scott MO, Fischbech KH, Kornegay JN, Avery RJ, Williams JR, Schmuckel RD, Sylvester JE (1988). The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334: 154—156.[CrossRef][Medline] [Order article via Infotrieve]
  • Coulton GR, Morgan JE, Partridge TA, Sloper JC (1988). The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 14: 53—70.[Web of Science][Medline] [Order article via Infotrieve]
  • Emery A. (2002). The muscular dystrophies. Lancet 359: 687—695.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Finsterer J., Stollberger C. (2000). Cardiac involvement in primary myopathies. Cardiology 94: 1—11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hoffman EP, Brown RHJ, Kunkel LM (1987). Dystrophin: The protein product of Duchenne muscular dystrophy locus. Cell 51: 919—928.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hoffman EP, Kunkel LM (1989). Dystrophin abnormalities in Duchenne/ Becker muscular dystrophy. Neuron 2: 1019—1029.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kaplan JC, Fontaine B. (2001). Neuromuscular disorders: Gene location. Neuromuscul Disord 11: 221—229.[CrossRef][Medline] [Order article via Infotrieve]
  • Konieczny SF, Drobes BL, Menke SL, Taparowsky EJ (1989). Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene. Oncogene 4: 473—481.[Web of Science][Medline] [Order article via Infotrieve]
  • Koujitani T., Yasuhara K., Tamura T., Onodera H., Takagi H., Takizawa T., Hirose M., Hayashi Y., Mitsumori K. (2001). Lack of modifying effects of eugenol on development of lung proliferative lesions induced by urethane in transgenic mice carrying the human prototype c-Ha-ras gene. J Toxicol Sci 26: 129—139.[CrossRef][Medline] [Order article via Infotrieve]
  • La Rocca SA, Crouch DH, Gillespie DA (1994). c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be associated from cell transformation. Oncogene 9: 3499—3508.[Web of Science][Medline] [Order article via Infotrieve]
  • Megeney LA, Kablar B., Perry RL, Ying C., May L., Rudnicki MA (1999). Severe cardiomyopathy in mice lacking dystropin and MyoD. Proc Natl Acad Sci USA 96: 220—225.[Abstract/Free Full Text]
  • Meier H., Southard JL (1970). Muscular dystrophy in the mouse caused by an allele at the dy-locus. Life Sci 9: 137—144.[Web of Science][Medline] [Order article via Infotrieve]
  • Michelson AM, Russell ES, Hoffman PJ (1955). Dystrophia muscularis: A hereditary primary myopathy in the house mouse. Proc Natl Acad Sci USA 41: 1079—1084.[Free Full Text]
  • Miner JH, Wold BJ ( 1991). c-myc inhibition of MyoD and myogenininitiated myogenic differentiation. Mol Cell Biol 11: 2842—2851.[Abstract/Free Full Text]
  • Mitsumori K., Wakana S., Yamamoto S., Kodama Y., Yasuhara K., Nomura T., Hayashi Y., Maronpot R. (1997). Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in ashort-term carcingenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mol Carcinog 20: 298—307.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ogasawara H., Tsutsumi M., Takeda K., Usui K., Kobayashi H., Murakami H., Takagi H, Kumagai, Konishi Y (2000). Utility of transgenic mice carrying human prototype c-Ha-ras gene for alternative carcinogenicity testing of chemicals—Negative results with methapyrilene hydrochloride. J Toxicol Pathol 13: 179—188.[CrossRef]
  • Olson EN, Spizz G., Tainsky MA (1987). The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol 7: 2104—2111.[Abstract/Free Full Text]
  • Ramocki MB, White MA, Konieczny SF, Taparowsky EJ (1998). A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis. J Biol Chem 273: 17696—17701.[Abstract/Free Full Text]
  • Robinson D. (1998). The international life sciences institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol Pathol 26: 474—475.[Free Full Text]
  • Sabourin AL, Rudnicki MA (2000). The molecular regulation of myogenesis. Clin Genet 57: 16—25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M. (1990). Most tumors in transgenic mice with human c-Ha-ras-gene contained somatically activated trangene. Oncogene 5: 1195—1200.[Web of Science][Medline] [Order article via Infotrieve]
  • Tanabe Y., Woo M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M. (1990). X chromosome-linked muscular dystrophy (mdx) of the skeletal muscle, mouse. In: Cardiovascular and Musculoskeletal Systems, Jones T, Mohr U, Hunt RD (eds). Springer-Verlag, Berlin, pp 149—155.
  • Torii M., Itoh F., Yabuuchi K., Ohno K., Kominami G., Hirano K., Tasaki T., Nara H. ( 2001). Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg rasH2 mice. J Toxicol Sci 26: 61—73.[CrossRef][Medline] [Order article via Infotrieve]
  • Torres LF, Duchen LW (1987). The mutant mdx: Inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 110: 269—299.[Abstract/Free Full Text]
  • Trainer DL, Kline T., McCabe FL, Faucette LF, Feild J., Chaikin M., Anzano M., Rieman D., Hoffstein S., Li DJ (1988). Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 41: 287—296.[Web of Science][Medline] [Order article via Infotrieve]
  • Watanabe K., Yamada K., Mizutani T., Totuka T. (1993). Elevation of the level of thiobarbituric acid-reactive products in hindleg skeletal muscle of dystrophic mice, but non-elevation in tongue muscle. FreeRadRes Commun 19: 93—100.
  • Weyman CM, Wolfman A. (1997). Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast. Oncogene 15: 2521— 2528.
  • Wirtz P., Loremans HM, Peer PG, Reintjes AG (1983). Postnatal growth and differentiation of muscle fibers in the mouse. II. A histochemical and morphometric investigation of dystrophic muscle. J Anat 137: 127—142.[Web of Science][Medline] [Order article via Infotrieve]
  • Yamamoto S., Hayashi Y., Mitsumori K., Nomura T. (1997). Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab Anim Sci 47: 121—126.[Web of Science][Medline] [Order article via Infotrieve]
  • Yamamoto S., Urano K., Koizumi H., Wakana S., Hioki K., Mitsumori K., Kurokawa Y., Hayashi Y., Nomura T. (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras-gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 106 (suppl 1): 57—69.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 30, No. 4, 501-506 (2002)
DOI: 10.1080/01926230290105677


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
M. Okamura, M. Moto, M. Muguruma, T. Ito, M. Jin, Y. Kashida, and K. Mitsumori
A 26-Week Carcinogenicity Study of 2-Amino-3-Methylimidazo[4,5-f]Quinoline in rasH2 Mice
Toxicol Pathol, February 1, 2006; 34(2): 199 - 205.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tsuchiya, T.
Right arrow Articles by Mutai, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchiya, T.
Right arrow Articles by Mutai, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?